These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22519027)

  • 21. [Marine n-3 polyunsaturated fatty acids and coronary heart disease. Background and status].
    Schmidt EB
    Ugeskr Laeger; 2005 May; 167(18):1940-2. PubMed ID: 15929265
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of n-3 fatty acids on atherosclerosis and the vascular response to injury.
    Goodnight SH
    Arch Pathol Lab Med; 1993 Jan; 117(1):102-6. PubMed ID: 8418754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
    Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE
    Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. n-3 polyunsaturated fatty acids after coronary artery bypass grafting.
    Benedetto U; Melina G; di Bartolomeo R; Angeloni E; Sansone D; Falaschi G; Capuano F; Comito C; Roscitano A; Sinatra R
    Ann Thorac Surg; 2011 Apr; 91(4):1169-75. PubMed ID: 21440140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of omega-3 fatty acid supplementation in primary and secondary prevention of coronary heart disease.
    Weisman D; Motro M; Schwammenthal E; Fisman EZ; Tenenbaum A; Tanne D; Adler Y
    Isr Med Assoc J; 2004 Apr; 6(4):227-32. PubMed ID: 15115262
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibitory effects of omega-3 polyunsaturated fatty acids on receptor-mediated non-selective cation currents in rat A7r5 vascular smooth muscle cells.
    Asano M; Nakajima T; Iwasawa K; Hazama H; Omata M; Soma M; Yamashita K; Okuda Y
    Br J Pharmacol; 1997 Apr; 120(7):1367-75. PubMed ID: 9105714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids.
    Robinson JG; Stone NJ
    Am J Cardiol; 2006 Aug; 98(4A):39i-49i. PubMed ID: 16919516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarrhythmic effects of n-3 polyunsaturated fatty acids.
    Wongcharoen W; Chattipakorn N
    Asia Pac J Clin Nutr; 2005; 14(4):307-12. PubMed ID: 16326636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. n-3 Polyunsaturated fatty acids are still underappreciated and underused post myocardial infarction.
    Khavandi A; Khavandi K; Greenstein A; Karsch K; Heagerty AM
    Heart; 2009 Apr; 95(7):540-1. PubMed ID: 19131442
    [No Abstract]   [Full Text] [Related]  

  • 30. Fish, marine n-3 polyunsaturated fatty acids and coronary heart disease: a minireview with focus on clinical trial data.
    Schmidt EB; Rasmussen LH; Rasmussen JG; Joensen AM; Madsen MB; Christensen JH
    Prostaglandins Leukot Essent Fatty Acids; 2006 Sep; 75(3):191-5. PubMed ID: 16844362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease.
    Fassett RG; Gobe GC; Peake JM; Coombes JS
    Am J Kidney Dis; 2010 Oct; 56(4):728-42. PubMed ID: 20493605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does the n-3 fatty acid alpha-linolenic acid have an impact on coronary heart disease?
    Cunningham E
    J Am Diet Assoc; 2005 Nov; 105(11):1825. PubMed ID: 16256769
    [No Abstract]   [Full Text] [Related]  

  • 33. Omega-3 fatty acids and cardiovascular disease.
    von Schacky C
    Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):129-35. PubMed ID: 17284999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.
    Berstad P; Seljeflot I; Veierød MB; Hjerkinn EM; Arnesen H; Pedersen JI
    Clin Sci (Lond); 2003 Jul; 105(1):13-20. PubMed ID: 12589702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marine lipids: overview "news insights and lipid composition of Lyprinol".
    Sinclair AJ; Murphy KJ; Li D
    Allerg Immunol (Paris); 2000 Sep; 32(7):261-71. PubMed ID: 11094639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data.
    De Caterina R; Madonna R; Bertolotto A; Schmidt EB
    Diabetes Care; 2007 Apr; 30(4):1012-26. PubMed ID: 17251279
    [No Abstract]   [Full Text] [Related]  

  • 37. Omega-3 fatty acids, atherogenesis, and endothelial activation.
    De Caterina R; Zampolli A
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8 Suppl 1():S11-4. PubMed ID: 17876190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
    Bays HE; Tighe AP; Sadovsky R; Davidson MH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Atheroma and fish oils].
    Marcantoni JP; Biason P
    Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():175-80. PubMed ID: 1285700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence polyunsaturated fatty acids omega-3 on coagulation and fibrinolysis systems in patients with NIDDM].
    Panchenko VM; Karabasova MA; Liutova LV; Togoev AM; Ershov AA; Chernova GI; Isaev VA
    Klin Med (Mosk); 2002; 80(2):40-3. PubMed ID: 11898721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.